Ductal carcinoma in situ of the breast: Increasing importance of radiotherapy as a part of the therapy approach

Strahlentherapie und Onkologie

Volumn 180, Issue 11, 2004, Pages 682-689

  Fietkau, Rainer ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Breast cancer; Ductal carcinoma in situ DCIS; Radiotherapy

Indexed keywords

ESTROGEN RECEPTOR; HORMONE; TAMOXIFEN;

AGE; BREAST CARCINOMA; CANCER CONTROL; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CARCINOMA IN SITU; CELL DIFFERENTIATION; FOLLOW UP; HORMONAL THERAPY; HUMAN; INCIDENCE; IRRADIATION; MASTECTOMY; NECROSIS; PRACTICE GUIDELINE; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZATION; RETROSPECTIVE STUDY; REVIEW; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA, DUCTAL; FEMALE; HUMANS; MASTECTOMY; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 11144311218     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-004-9192-1     Document Type: Review

References (49)

1. Albrecht MR, Zink K, Busch W, et al. Dissection or irradiation of the axilla in postmenopausal patients with breast cancer? Long-term results and long-term effects in 655 patients. Strahlenther Onkol 2002;178:510-6.
2. Allred DC, Bryant J, Land S, et al. Estrogen receptor expression as a predictive marker of effectiveness of tamoxifen in the treatment of DCIS: findings from NSABP protocol B-24. Breast Cancer Res Treat 2002;76:Suppl 1:S36. abstract.
3. Baxter NN, Viring BA, Durham SB, et al. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 2004;96:443-8.
4. Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast conserving therapy for ductal carcinoma in situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001;19:2263-71.
5. Boland GP, Chan KC, Knox WF, et al. Value of the van Nuys prognostic index in prediction of recurrence of ductal carcinoma in situ after breast conserving surgery. Br J Surg 2003;90:426-32.
6. Boyages J, Delany G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ. A meta-analysis. Cancer 1999;85:616-28.
7. Burstein HJ, Polyak K, Wong JS, et al. Ductal carcinoma in situ of the breast. N Engl J Med 2004;350:1430-41.
8. Cutuli B, Cohen-Solal-Le N, DeLafontan B, et al. Breast conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centre's experience. Int J Radiat Oncol Biol Phys 2002;53:868-79.
9. De Mascarel I, Bonchion F, MacGrogan G, et al. Application of the van Nuys prognostic index in a retrospective series of 367 ductal carcinomas of the breast examined by serial macroscopic sectioning: practical considerations. Breast Cancer Res Treat 2000;61:151-9.
10. Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328:1581-6.
11. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: NSABP B-24 randomised controlled trial. Lancet 1999; 353:1993-2000.
12. Fisher B, Land S, Mamounas E, et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 2001;28: 400-18.
13. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the NSABP: eight year update of Protocol B-17: intraductal carcinoma. Cancer 1999; 86:429-38.
14. Fodor J, Polgar C, Major T, et al. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation - the significance of tumor size. Strahlenther Onkol 2003;179:197-202.
15. Gao X, Fisher SG, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early stage breast cancer: a population based study. Int J Radiat Oncol Biol Phys 2003;56:1038-45.
16. Gerlach B, Audretsch W, Gogolin F, et al. Remission rates in breast cancer treated with preoperative chemotherapy and radiotherapy. Strahlenther Onkol 2003;179:306-11.
17. Gruber G, Berclaz G, Altermatt HJ, et al. Can the addition of regional radiotherapy counterbalance important risk factors in breast cancer patients with extracapsular invasion of axillary lymph node metastases? Strahlenther Onkol 2003;179:661-6.
18. Harms W, Krempien R, Hensley FW, et al. 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer. Strahlenther Onkol 2002;178:607-14.
19. Hehr T, Budach W, Durst I, et al. Postmastectomy electron-beam-rotation irradiation in locally advanced breast cancer - prognostic factors of locoregional tumor control. Strahlenther Onkol 2002;178:624-32.
20. Julien JP, Bijker N, Fentiman IS, et al. Radiotherapy in breast conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 2000;355:528-33.
21. Mayer A, Naszaly A, Patyanik M, et al. Perioperative brachytherapy for pretreated chest wall recurrence of breast cancer. Strahlenther Onkol 2002;178:633-6.
22. Morrow M. The certainties and the uncertainties of ductal carcinoma in situ. J Natl Cancer Inst 2004;96:424-5.
23. Nagel G, Röhrig B, Hoyer H, et al. Bevölkerungsbezogene Studie über die Anwendung adjuvanter Strahlentherapie bei Patientinnen mit Mammakarzinom. Strahlenther Onkol 2002;178:589-96.
24. Nakamura S, Woo C, Silberman H, et al. Breast conserving therapy for ductal carcinoma in situ: a 20 year experience with excision plus radiation therapy. Am J Surg 2002;184:403-9.
25. Neuschatz AC, DiPetrillo T, Safaii H. Margin width as a determinant of local control with or without radiation therapy for ductal carcinoma in situ of the breast. Int J Cancer 2001;96:Suppl:97-104.
26. Neuschatz AC, DiPetrillo T, Steinhoff M, et al. The value of breast lumpectomy margin assessment as a predictor of residual tumour burden in ductal carcinoma of the breast. Cancer 2002;94:1917-24.
27. Polgar C, Fodor J, Major T, et al. Radiotherapy confined to the tumour bed following breast conserving surgery. Current status, controversies and future prospects. Strahlenther Onkol 2002;178:597-606.
28. Polgar C, Fodor J, Orosz Z, et al. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer: first results of the randomized Budapest boost trial. Strahlenther Onkol 2002;178: 615-23.
29. Provenzano E, Hopper JL, Giles GG, et al. Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study. Pathology 2004;36:221-9.
30. Rodrigues N, Carter D, Dillon D. Correlation of clinical and pathological features with outcome in patients with ductal carcinoma in situ of the breast treated with breast conserving surgery and radiotherapy. Int J Radiat Oncol Biol Phys 2002;54:1331-5.
31. Roka S, Rudas M, Taucher S, et al. High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS. Eur J Surg Oncol 2004;30:243-7.
32. Sauer R. The effect of local control on overall survival after the breast conserving therapy of breast carcinoma. Strahlenther Onkol 1996;172:181-5.
33. Sauer R. Radiation therapy after mastectomy - interdisciplinary consensus puts an end to a controversy. German Society of Senology. Strahlenther Onkol 2001;177:1-9.
34. Sauer R, Schauer A, Rauschecker HF, et al. Therapy of small breast cancer: a prospective study on 1036 patients with special emphasis on prognostic factors. Int J Radiat Oncol Biol Phys 1992;23:907-14.
35. Sautter-Bihl ML, Hültenschmidt B, Melcher U, et al. Radiotherapy of internal mammary lymph nodes in breast cancer. Principle considerations on the basis dosimetric data. Strahlenther Onkol 2002;178:18-24.
36. Schuck A, Könemann S, Heinen K, et al. Microscopic residual cancer is a risk factor in the primary treatment of breast cancer. Strahlenther Onkol 2002; 178:307-13.
37. Schuller P, Bruns F, Hesselmann S, et al. Simulator verification of the accuracy of patient repositioning after virtual simulation. Is physical simulation still needed? Strahlenther Onkol 2002;178:715-21.
38. Silverstein MJ. The University of Southern California/van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg 2003;186: 337-43.
39. Silverstein MJ. An argument against routine use of radiotherapy for ductal carcinomas in situ. Oncology 2003;11:1511-33.
40. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 1999;340:1455-61.
41. Silverstein MJ, Poller DN, Waiman JR. Prognostic classification of breast ductal carcinoma in situ. Lancet 1995;345:1154-7.
42. Solin LJ, Fourquet A, Vicini FA, et al. Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long term outcome and prognostic significance of patient age and margin status. Int J Radiat Oncol Biol Phys 2001; 50:991-1002.
43. Solin LJ, Kurtz J, Fourquet A, et al. Fifteen year results of breast conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 1996;14:754-63.
44. Thilmann C, Zabel A, Kuhn S, et al. Inversely planned intensity modulated radiotherapy for irradiation of a woman with breast cancer and funnel chest. Strahlenther Onkol 2002;178:637-43.
45. Tunon-de-Lara C, de Mascarel I, MacGrogan G, et al. Analysis of 676 cases of ductal carcinoma in situ of the breast from 1971 to 1995. Diagnosis and treatment - the experience of one institute. Am J Clin Oncol 2001;24: 531-6.
46. UK Coordinating Committee on Cancer Research Ductal Carcinoma In Situ (DCIS) Working Party. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia and New Zealand: randomised controlled trial. Lancet 2003;362:95-102.
47. Vicini FA, Kestin LL, Goldstein NS, et al. Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast conserving therapy. J Clin Oncol 2000;18:296-306.
48. Vicini FA, Recht A. Age at diagnosis and outcome for women with ductal carcinoma in situ of the breast: a critical review of the literature. J Clin Oncol 2002;20:2736-44.
49. Wong J, Gadd M, Gelman R, et al. Wide excision alone for ductal carcinoma in situ of the breast. Proceedings of the 26th Annual San Antonio Breast Cancer Symposium. Breast Cancer Res Treat 2003;82(Suppl 1):S10. abstract.